Time to stop counting the tablets?
- 1 August 1989
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 46 (2), 163-168
- https://doi.org/10.1038/clpt.1989.121
Abstract
We attempted to assess compliance using both a pharmacologic indicator (low-dose phenobarbital) and a return tablet count in 225 patients who were taking part in three separate studies. The were 216 patients (96%) who kept a follow-up appointment after 28 days; 161 patients appeared to have good compliance (90% to 109%) by return tablet count. Of these 161 patients, 51 (32%) had plasma phenobarbital concentrations (corrected for dose and weight) that were less than 90% of the lowest value previously found in normal volunteers, which suggested poorer compliance. When compared with the age-related volunteer values, 77 (48%) had values that were less than 90% of the lowest volunteer values. There were 6 of 10 patients with apparently excessive (.gtoreq. 110%) compliance by return tablet count and 4 of 12 who failed to return their container who also had phenobarbital concentrations that were less than 90% of the lowest volunteer value. We concluded that return tablet count grossly overestimates compliance.This publication has 11 references indexed in Scilit:
- Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times dailyClinical Pharmacology & Therapeutics, 1988
- Measuring treatment compliance of men with non-gonococcal urethritis receiving oxytetracycline combined with low dose phenobarbitone.Sexually Transmitted Infections, 1988
- The paradox of using a 7 day antibacterial course to treat urinary tract infections in the community.British Journal of Clinical Pharmacology, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Minimal doses of digoxin: A new marker for compliance to medicationEuropean Heart Journal, 1987
- Low‐dose phenobarbitone as an indicator of compliance with drug therapy.British Journal of Clinical Pharmacology, 1987
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- RANITIDINE AND CIMETIDINE IN PREVENTION OF DUODENAL ULCER RELAPSE *1A Double-blind, Randomised, Multicentre, Comparative TrialThe Lancet, 1984
- Understanding and Improving Patient ComplianceAnnals of Internal Medicine, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983